Waning David L, Lehman Jason A, Batuello Christopher N, Mayo Lindsey D
Herman B Wells Center for Pediatric Research, 980 West Walnut, Walther Hall R3-C548, Indianapolis, IN 46202, USA.
Pharmaceuticals (Basel). 2010 May 18;3(5):1576-1593. doi: 10.3390/ph3051576.
The p53 tumor suppressor is a key protein in maintaining the integrity of the genome by inducing either cell cycle arrest or apoptosis following cellular stress signals. Two human family members, Mdm2 and Mdmx, are primarily responsible for inactivating p53 transcription and targeting p53 protein for ubiquitin-mediated degradation. In response to genotoxic stress, post-translational modifications to p53, Mdm2 and Mdmx stabilize and activate p53. The role that phosphorylation of these molecules plays in the cellular response to genotoxic agents has been extensively studied with respect to cancer biology. In this review, we discuss the main phosphorylation events of p53, Mdm2 and Mdmx in response to DNA damage that are important for p53 stability and activity. In tumors that harbor wild-type p53, reactivation of p53 by modulating both Mdm2 and Mdmx signaling is well suited as a therapeutic strategy. However, the rationale for development of kinase inhibitors that target the Mdm2-Mdmx-p53 axis must be carefully considered since modulation of certain kinase signaling pathways has the potential to destabilize and inactivate p53.
p53肿瘤抑制蛋白是一种关键蛋白,通过在细胞应激信号后诱导细胞周期停滞或凋亡来维持基因组的完整性。人类的两个家族成员Mdm2和Mdmx主要负责使p53转录失活,并将p53蛋白靶向泛素介导的降解。响应基因毒性应激,对p53、Mdm2和Mdmx的翻译后修饰可稳定并激活p53。就癌症生物学而言,这些分子的磷酸化在细胞对基因毒性剂的反应中所起的作用已得到广泛研究。在本综述中,我们讨论了p53、Mdm2和Mdmx在响应DNA损伤时的主要磷酸化事件,这些事件对p53的稳定性和活性很重要。在携带野生型p53的肿瘤中,通过调节Mdm2和Mdmx信号来重新激活p53非常适合作为一种治疗策略。然而,由于调节某些激酶信号通路有可能使p53不稳定并失活,因此必须谨慎考虑开发靶向Mdm2-Mdmx-p53轴的激酶抑制剂的基本原理。